publication venue for
- Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency. 2020
- Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer.. 4. 2023
- Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions.. 4. 2023
- Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer.. 4. 2023
- Mucosal-homing natural killer cells are associated with aging in persons living with HIV.. 3. 2022
- Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibody.. 3. 2022
- System-wide transcriptome damage and tissue identity loss in COVID-19 patients.. 3. 2022
- Molecular predictors of response to pembrolizumab in thymic carcinoma.. 2. 2021
- A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice.. 2. 2021
- Different evolutionary pathways of HIV-1 between fetus and mother perinatal transmission pairs indicate unique immune selection in fetuses.. 2. 2021
- ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder.. 1. 2020
- DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden.. 1. 2020
- Moving diversity, equity, and inclusion from opinion to evidence.. 3. 2022
- Teach 'em young: Influenza vaccines induce broadly neutralizing antibodies in children. 2022
- Senescence Inflames the Pancreatic Tumor Microenvironment. 2020
- Deep generative molecular design reshapes drug discovery. 2022